Effect of Huangqi injection on short-term prognosis in children with acute lymphoblastic leukemia

Chinese Journal of Contemporary Pediatrics

Volumn 16, Issue 2, 2014, Pages 141-146

  Yan, Pei Hua ^a   Yan, Mei ^a   Wang, Xue Mei ^a   Wang, Shu Hong ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Acute lymphoblastic leukemia; Child; Huangqi; Short term prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; HUANGQI; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER PROGNOSIS; CANCER THERAPY; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; REMISSION INDUCTION THERAPY; RETROSPECTIVE STUDY;

ASTRAGALUS PLANT; CHILD; CHILD, PRESCHOOL; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INCIDENCE; INJECTIONS; MALE; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 84898911448     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: 10.7499/j.issn.1008-8830.2014.02.009     Document Type: Article

References (11)

1. Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study[J]. Blood, 2008, 111(12): 5477-5485.